The role of RhoC in the proliferation and apoptosis of hepatocellular carcinoma cells

Medical Oncology

Volumn 29, Issue 3, 2012, Pages 1802-1809

  Xie, Shuli ^a   Zhu, Mingguang ^b   Lv, Guoyue ^a   Zhang, Qiang ^a   Wang, Guangyi ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Apoptosis; Cell growth; Cell proliferation; Hepatocellular carcinoma; RhoC

Indexed keywords

DNA; PROTEIN BAX; PROTEIN P16; PROTEIN P21; RHO FACTOR; RHOC PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; CANCER CELL; CELL ASSAY; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IN VITRO SELECTION; LIVER CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; FLOW CYTOMETRY; GENE KNOCKDOWN TECHNIQUES; HUMANS; LIVER NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHO GTP-BINDING PROTEINS;

EID: 84871773123     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-011-0003-0     Document Type: Article

References (35)

1. Schutte K, Bornschein J, Malfertheiner P. Hepatocellular carcinoma-epidemiological trends and risk factors. Dig Dis. 2009; 27:80-92.
2. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557-76.
3. Wang W, et al. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis. Br J Cancer. 2004;90:2349-55.
4. Blum HE. Spangenberg HC.Hepatocellular carcinoma: an update. Arch Iran Med. 2007;10:361-71.
5. Hwang LH. Gene therapy strategies for hepatocellular carcinoma. J Biomed Sci. 2006;13:453-68.
6. Beckers CM, van Hinsbergh VW, van Nieuw Amerongen GP. Driving Rho GTPase activity in endothelial cells regulates barrier integrity. Thromb Haemost. 2010;103:40-55.
7. Lazer G, Katzav S. Guanine nucleotide exchange factors for RhoGTPases: good therapeutic targets for cancer therapy? Cell Signal. 2011;23:969-79.
8. Wang N, et al. F-actin reorganization and inactivation of rho signaling pathway involved in the inhibitory effect of Coptidis Rhizoma on hepatoma cell migration. Integr Cancer Ther. 2010; 9:354-64.
9. Jiang H, Sha SH, Schacht J. Rac/Rho pathway regulates actin depolymerization induced by aminoglycoside antibiotics. J Neurosci Res. 2006;83:1544-51.
10. Rawe VY, Payne C, Schatten G. Profilin and actin-related proteins regulate microfilament dynamics during early mammalian embryogenesis. Hum Reprod. 2006;21:1143-53.
11. Watanabe N, et al. p140mDia, a mammalian homolog of Drosophila diaphanous, is a target protein for Rho small GTPase and is a ligand for profilin. EMBO J. 1997;16:3044-56.
12. Jockusch BM, Murk K, Rothkegel M. The profile of profilins. Rev Physiol Biochem Pharmacol. 2007;159:131-49.
13. Ikoma T, et al. A definitive role of RhoC in metastasis of orthotopic lung cancer in mice. Clin Cancer Res. 2004;10: 1192-200.
14. Zhao Y, Zong ZH, Xu HM. RhoC expression level is correlated with the clinicopathological characteristics of ovarian cancer and the expression levels of ROCK-I, VEGF, and MMP9. Gynecol Oncol. 2010;116:563-71.
15. Wang W, et al. RhoC is essential for angiogenesis induced by hepatocellular carcinoma cells via regulation of endothelial cell organization. Cancer Sci. 2008;99:2012-8.
16. Wang W, et al. Expression and significance of RhoC gene in hepatocellular carcinoma. World J Gastroenterol. 2003;9:1950-3.
17. Yoon SY, et al. Construction of a vector generating both siRNA and a fluorescent reporter: a siRNA study in cultured neurons. Mol Cells. 2004;18:127-30.
18. Quinones-Hinojosa A, et al. Techniques to assess the proliferative potential of brain tumors. J Neurooncol. 2005;74:19-30.
19. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6:674-87.
20. Karlsson R, et al. Rho GTPase function in tumorigenesis. Biochim Biophys Acta. 2009;1796:91-8.
21. Chen X, et al. Gene expression patterns in human liver cancers. Mol Biol Cell. 2002;13:1929-39.
22. Okabe H, et al. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res. 2001;61:2129-37.
23. Hakem A, et al. RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis. Genes Dev. 2005;19: 1974-9.
24. He X, et al. The effect of RhoC siRNA on the invasiveness and proliferation of human cervical cancer cell line SiHa cells. J Huazhong Univ Sci Technolog Med Sci. 2008;28:665-9.
25. Pille JY, et al. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo. Mol Ther. 2005;11:267-74.
26. Faried A, et al. RhoA and RhoC proteins promote both cell proliferation and cell invasion of human oesophageal squamous cell carcinoma cell lines in vitro and in vivo. Eur J Cancer. 2006; 42:1455-65.
27. Alao JP. The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol Cancer. 2007;6:1-16.
28. Liggett WH, Sidransky D. Role of the p16 tumor suppressor gene in cancer. J Clin Oncol. 1998;16:1197-206.
29. Rocco JW, Sidransky D. p16(MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res. 2001;264:42-55.
30. Jung P, Hermeking H. The c-MYC-AP4-p21 cascade. Cell Cycle. 2009;8:982-9.
31. Croft DR. Olson MF: the Rho GTPase effector ROCK regulates cyclin A, cyclin D1, and p27Kip1 levels by distinct mechanisms. Mol Cell Biol. 2006;26:4612-27.
32. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57-70.
33. Ding J, Zhang Z, Roberts GJ, Falcone M, Miao Y, Shao Y, Zhang XC, Andrews DW, Lin J. Bcl-2 and Bax interact via the BH1-3 groove-BH3 motif interface and a novel interface involving the BH4 motif. J Biol Chem. 2010;285:28749-63.
34. Roberts AB, Wakefield LM. The two faces of transforming growth factor beta in carcinogenesis. Proc Natl Acad Sci USA. 2003;100:8621-3.
35. Yin X, Dewille JW, Hai T. A potential dichotomous role of ATF3, an adaptive-response gene, in cancer development. Oncogene. 2008;27:2118-27.